Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
PDUFA VII: US FDA Says Money Can’t Solve Meeting Problems
Mar 19 2021
•
By
Derrick Gingery
The FDA said time, not money, is the issue with adding a mid-cycle meeting for prior approval manufacturing supplements. • Source: Shutterstock
More from User Fees
More from Pathways & Standards